Page last updated: 2024-08-24

7-aminoactinomycin d and Breast Cancer

7-aminoactinomycin d has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alsherbiny, MA; Bhuyan, DJ; Chang, D; Li, CG; Low, MN1
Dudek, AZ; Jasinski, P; Terai, K; Zwolak, P1

Other Studies

2 other study(ies) available for 7-aminoactinomycin d and Breast Cancer

ArticleYear
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
    International journal of molecular sciences, 2021, Sep-18, Volume: 22, Issue:18

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cannabidiol; Cell Line, Tumor; Cell Survival; Dactinomycin; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Irinotecan; MCF-7 Cells; Paclitaxel; Proteome; Proteomics; Vinorelbine

2021
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:9

    Topics: Annexin A5; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 9; Cell Survival; Cytosol; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gamma Rays; Humans; Indoles; Phosphorylation; Protein Kinase C; Radiation-Sensitizing Agents; Repressor Proteins; Tumor Cells, Cultured

2008